Evidence map›Paper›PMID 25923134›Full record

ArticlePloS one2015

Development and characterization of an effective food allergy model in Brown Norway rats.

Mar Abril-Gil, Alba Garcia-Just, Francisco J Pérez-Cano, Àngels Franch, Margarida Castell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mar Abril-GilDepartament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain; Institut de Recerca en Nutrició i Seguretat Alimentària, Universitat de Barcelona (INSA-UB), Barcelona, Spain.
Alba Garcia-JustDepartament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain; Institut de Recerca en Nutrició i Seguretat Alimentària, Universitat de Barcelona (INSA-UB), Barcelona, Spain.
Francisco J Pérez-CanoDepartament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain; Institut de Recerca en Nutrició i Seguretat Alimentària, Universitat de Barcelona (INSA-UB), Barcelona, Spain.
Àngels FranchDepartament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain; Institut de Recerca en Nutrició i Seguretat Alimentària, Universitat de Barcelona (INSA-UB), Barcelona, Spain.
Margarida CastellDepartament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain; Institut de Recerca en Nutrició i Seguretat Alimentària, Universitat de Barcelona (INSA-UB), Barcelona, Spain.
Universitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFood allergy (FA) is an adverse health effect produced by the exposure to a given food. Currently, there is no optimal animal model of FA for the screening of immunotherapies or for testing the allergenicity of new foods.

objectiveThe aim of the present study was to develop an effective and rapid model of FA in Brown Norway rats. In order to establish biomarkers of FA in rat, we compared the immune response and the anaphylactic shock obtained in this model with those achieved with only intraperitoneal immunization.

methodsRats received an intraperitoneal injection of ovalbumin (OVA) with alum and toxin from Bordetella pertussis, and 14 days later, OVA by oral route daily for three weeks (FA group). A group of rats receiving only the i.p. injection (IP group) were also tested. Serum anti-OVA IgE, IgG1, IgG2a, IgG2b and IgA antibodies were quantified throughout the study. After an oral challenge, body temperature, intestinal permeability, motor activity, and mast cell protease II (RMCP-II) levels were determined. At the end of the study, anti-OVA intestinal IgA, spleen cytokine production, lymphocyte composition of Peyer's patches and mesenteric lymph nodes, and gene expression in the small intestine were quantified.

resultsSerum OVA-specific IgG1, IgG2a and IgG2b concentrations rose with the i.p. immunization but were highly augmented after the oral OVA administration. Anti-OVA IgE increased twofold during the first week of oral OVA gavage. The anaphylaxis in both IP and FA groups decreased body temperature and motor activity, whereas intestinal permeability increased. Interestingly, the FA group showed a much higher RMCP II serum protein and intestinal mRNA expression.

conclusionsThese results show both an effective and relatively rapid model of FA assessed by means of specific antibody titres and the high production of RMCP-II and its intestinal gene expression.

Indexed as

AnimalsBiomarkersBordetella pertussisDisease Models, AnimalFood HypersensitivityGene Expression RegulationHumansImmunoglobulin AImmunoglobulin EImmunoglobulin GIntestinesOvalbuminRatsSerine EndopeptidasesBiomarkerscytotoxic T lymphocyte-specific serine proteaseImmunoglobulin AImmunoglobulin EImmunoglobulin GOvalbuminSerine Endopeptidases

Identifiers

PMID25923134
PMCPMC4414460
OpenAlexW2022391113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.